We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.1B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$575M |
| 5 |
Cisco
CSCO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.73B |
| 3 |
UnitedHealth
UNH
|
+$856M |
| 4 |
Apple
AAPL
|
+$577M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.82% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
2901
DELISTED
Y-mAbs Therapeutics
YMAB
| $421K | ﹤0.01% |
93,418
-19,065
| -17% | -$85.7K |
|
2902
W&T Offshore
WTI
$545M
| $420K | ﹤0.01% |
254,662
-50,011
| -16% | -$73.7K |
|
2903
Rimini Street
RMNI
$408M
| $419K | ﹤0.01% |
111,012
-24,959
| -18% | -$83.4K |
|
2904
Plumas Bancorp
PLBC
$427M
| $418K | ﹤0.01% |
9,411
-2,387,623
| -100% | -$103M |
|
2905
Crawford & Co Class A
CRD.A
$536M
| $418K | ﹤0.01% |
39,489
-23,316
| -37% | -$248K |
|
2906
Digimarc Corp
DMRC
$133M
| $417K | ﹤0.01% |
31,597
-25,974
| -45% | -$333K |
|
|
ESPR
2907
DELISTED
Esperion Therapeutics
ESPR
| $416K | ﹤0.01% |
422,613
-2,665,087
| -86% | -$2.67M |
|
|
EWCZ
2908
DELISTED
European Wax Center
EWCZ
| $415K | ﹤0.01% |
73,687
-17,828
| -19% | -$81K |
|
|
GBFH
2909
GBank Financial Holdings
GBFH
$449M
| $414K | ﹤0.01% |
+11,689
| New | +$458K |
|
|
BCAX
2910
Bicara Therapeutics
BCAX
$1.78B
| $413K | ﹤0.01% |
44,437
+19,409
| +78% | +$231K |
|
2911
Donegal Group Class A
DGICA
$695M
| $411K | ﹤0.01% |
20,503
-7,812
| -28% | -$151K |
|
2912
PCB Bancorp
PCB
$400M
| $410K | ﹤0.01% |
19,536
-775
| -4% | -$15K |
|
2913
Aldeyra Therapeutics
ALDX
$91.7M
| $409K | ﹤0.01% |
106,705
-241,816
| -69% | -$625K |
|
2914
Colony Bankcorp
CBAN
$462M
| $407K | ﹤0.01% |
24,682
-8,393
| -25% | -$130K |
|
2915
Ponce Financial Group
PDLB
$489M
| $406K | ﹤0.01% |
29,355
-400,360
| -93% | -$5.16M |
|
2916
Virco
VIRC
$94.4M
| $399K | ﹤0.01% |
49,963
-67,482
| -57% | -$593K |
|
|
ONIT
2917
Onity Group
ONIT
$333M
| $398K | ﹤0.01% |
10,436
-3,281
| -24% | -$116K |
|
2918
LENSAR
LNSR
$68.8M
| $396K | ﹤0.01% |
30,061
+12,196
| +68% | +$165K |
|
|
ORKA
2919
Oruka Therapeutics
ORKA
$5.56B
| $396K | ﹤0.01% |
+35,313
| New | +$368K |
|
|
TRUE
2920
DELISTED
TrueCar
TRUE
| $395K | ﹤0.01% |
207,689
-44,667
| -18% | -$68.2K |
|
2921
Timberland Bancorp
TSBK
$343M
| $392K | ﹤0.01% |
12,562
-87
| -0.7% | -$2.65K |
|
2922
Hain Celestial
HAIN
$47.8M
| $391K | ﹤0.01% |
257,146
+25,938
| +11% | +$60.6K |
|
2923
Douglas Elliman
DOUG
$155M
| $390K | ﹤0.01% |
+168,188
| New | +$359K |
|
2924
Orange County Bancorp
OBT
$505M
| $390K | ﹤0.01% |
15,094
-4,836
| -24% | -$118K |
|
|
PHLT
2925
DELISTED
Performant Healthcare Inc
PHLT
| $390K | ﹤0.01% |
97,425
-33,846
| -26% | -$96K |
|
Similar funds
VFT
Nuveen's Q2 2025 Portfolio in Review
As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
- Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
- Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
- Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
- Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
- Nuveen opened 192 new positions and closed 199 in Q2 2025.
- Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.